It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Increasing evidence supports the role of brain and systemic inflammation in the etiology of Parkinson disease (PD). We used gene expression profiling to examine the activation state of peripheral blood monocytes in 18 patients with early, untreated PD and 16 healthy control (HC) subjects. Monocytes were isolated by negative selection, and gene expression studied by RNA-seq and gene set enrichment analysis. A computational model that incorporated case/control status, sex, and the interaction between case/control status and sex was utilized. We found that there was a striking effect of sex on monocyte gene expression. There was inflammatory activation of monocytes in females with PD, with enrichment of gene sets associated with interferon gamma stimulation. In males, the activation patterns were more heterogeneous. These data point to the importance of systemic monocyte activation in PD, and the importance of studies which examine the differential effects of sex on pathophysiology of the disease.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 University of Alabama at Birmingham, Alabama Morris K. Udall Center of Excellence in Parkinson’s Disease Research, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187); University of Alabama at Birmingham, Center for Clinical and Translational Science, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187); New Mexico State University, Department of Chemistry and Biochemistry, Las Cruces, USA (GRID:grid.24805.3b) (ISNI:0000 0001 0687 2182)
2 University of Alabama at Birmingham, Alabama Morris K. Udall Center of Excellence in Parkinson’s Disease Research, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187); University of Alabama at Birmingham, Department of Cell, Developmental and Integrative Biology, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187)
3 University of Alabama at Birmingham, Alabama Morris K. Udall Center of Excellence in Parkinson’s Disease Research, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187); University of Alabama at Birmingham, Center for Clinical and Translational Science, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187)
4 University of Alabama at Birmingham, Center for Clinical and Translational Science, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187)
5 University of Alabama at Birmingham, Alabama Morris K. Udall Center of Excellence in Parkinson’s Disease Research, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187)
6 University of Alabama at Birmingham, Alabama Morris K. Udall Center of Excellence in Parkinson’s Disease Research, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187); University of Alabama at Birmingham, Department of Neurology, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187)
7 University of Alabama at Birmingham, Alabama Morris K. Udall Center of Excellence in Parkinson’s Disease Research, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187); Duke University, Department of Pharmacology & Cancer Biology, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961)